SWK
52
-6
MDLZ
22
-2
VRSK
25
-3
SJM
12
-4
TJX
64
-2
DHR
64
-4
CINF
63
-3
HD
31
-3
EXR
22
-6
SIG
52
5
URBN
70
-4
T
27
-2
WHR
50
-5
GOOG
69
-2
HAL
47
-6
ESS
39
-5
NUE
57
4
OXY
33
-4
MCHP
45
-4
ADBE
52
-4
SWK
52
-6
MDLZ
22
-2
VRSK
25
-3
SJM
12
-4
TJX
64
-2
DHR
64
-4
CINF
63
-3
HD
31
-3
EXR
22
-6
SIG
52
5
URBN
70
-4
T
27
-2
WHR
50
-5
GOOG
69
-2
HAL
47
-6
ESS
39
-5
NUE
57
4
OXY
33
-4
MCHP
45
-4
ADBE
52
-4
Financhill
Back

Guggenheim Strategic Opportunities Fund Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
49

GOF
Guggenheim Strategic Opportunities Fund

Last Price:
$12.05
Seasonality Move:
0.63%
Buy
64

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$86.95
Seasonality Move:
-30.03%
Sell
49
Guggenheim Strategic Opportunities Fund (GOF) is a Sell

Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?

  • The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.07. The Score for GOF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • GOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GOF Stock Price Chart

What is Guggenheim Strategic Opportunities Fund's stock price today?

  • The Guggenheim Strategic Opportunities Fund share price today is $12.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $93.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

GOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 34.86 Sell
Chaikin Money Flow: 1717688 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.78 Buy
Relative Strength Index (14 RSI): 76.13 Buy
Chaikin Money Flow: 147064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.12 Sell
20-day SMA: 12.15 Sell
50-day SMA: 13.07 Sell
200-day SMA: 14.45 Sell
8-day EMA: 12.13 Sell
20-day EMA: 12.3 Sell
50-day EMA: 12.94 Sell
200-day EMA: 14.19 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.53 Buy
20-day SMA: 72.88 Buy
50-day SMA: 64.83 Buy
200-day SMA: 42.54 Buy
8-day EMA: 84.37 Buy
20-day EMA: 75.93 Buy
50-day EMA: 66.06 Buy
200-day EMA: 46.89 Buy

Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Guggenheim Strategic Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):